Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beshom Holdings BhdXKLS:7668 57 Debt-to-EBITDA is 0.66 as of Apr. 2026, which is 633% above its 10-year median of 0.09. GuruFocus rates XKLS:7668 with a GF Score™ of 57/100 and a GF Value™ of RM0.83 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Beshom Holdings Bhd ranks better than 76.52% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Beshom Holdings Bhd's Debt-to-EBITDA or its related term are showing as below:
XKLS:7668'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0.09 Max: 0.69
Current: 0.69
During the past 13 years, the highest Debt-to-EBITDA Ratio of Beshom Holdings Bhd was 0.69. The lowest was 0.00. And the median was 0.09.
XKLS:7668's Debt-to-EBITDA is ranked better than 76.52% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.18
vs XKLS:7668: 0.69
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Beshom Holdings Bhd Debt-to-EBITDA Related Terms
Beshom Holdings Bhd Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Beshom Holdings Bhd's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beshom Holdings Bhd Debt-to-EBITDA Competitor Comparison
For the Pharmaceutical Retailers subindustry, Beshom Holdings Bhd's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beshom Holdings Bhd Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beshom Holdings Bhd's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Beshom Holdings Bhd's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Apr. 2026) EBITDA data.
Beshom Holdings Bhd (XKLS:7668) has a Debt-to-EBITDA of 0.66 as of Apr. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Beshom Holdings Bhd. This is 633% above median its historical median of 0.09. According to the industry distribution chart, Beshom Holdings Bhd ranks #112 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 23.5%.
Is Beshom Holdings Bhd's Debt-to-EBITDA too high?
Beshom Holdings Bhd's current Debt-to-EBITDA of 0.66 is 633% above median its 10-year median of 0.09. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.18. Beshom Holdings Bhd's value of 0.66 is 69.7% below this industry median. Based on the distribution chart, Beshom Holdings Bhd ranks #112 out of 477 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Beshom Holdings Bhd has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beshom Holdings Bhd's Debt-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Beshom Holdings Bhd ranks #112 out of 477 companies for Debt-to-EBITDA. This places Beshom Holdings Bhd in the top 24% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.18. Beshom Holdings Bhd's value of 0.66 is 69.7% below this benchmark. While the company's 10-year median is 0.09 vs. the industry median of 2.18, Beshom Holdings Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.18, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beshom Holdings Bhd's current Debt-to-EBITDA of 0.66 is 69.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Beshom Holdings Bhd. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beshom Holdings Bhd's current Debt-to-EBITDA is 0.66, which is 633% above median its own 10-year median of 0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beshom Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Beshom Holdings Bhd (XKLS:7668) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.83, compared to a current price of RM0.54 — trading 35.5% below its estimated fair value. The current Debt-to-EBITDA is 0.66, which is 633% above median its 10-year median of 0.09 and 69.7% below the Healthcare Providers & Services industry median of 2.18. Beshom Holdings Bhd's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Beshom Holdings Bhd (XKLS:7668), the current Debt-to-EBITDA is 0.66 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beshom Holdings Bhd (XKLS:7668) Overvalued in 2026?
Based on GuruFocus' analysis, Beshom Holdings Bhd stock appears to be undervalued.
The current stock price of RM0.54 is trading 35.5% below its estimated GF Value™ of RM0.83.
GuruFocus considers Beshom Holdings Bhd to be Significantly Undervalued.
Key valuation signals for XKLS:7668:
Debt-to-EBITDA: 0.66 (633% above median its 10-year median of 0.09)
GF Value™: RM0.83 vs. price of RM0.54 (35.5% below fair value)
Industry Position: 69.7% below the Healthcare Providers & Services median (#112 of 477)
No single metric tells the full story. See the XKLS:7668 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beshom Holdings Bhd is involved in wholesale and retail, multi-level marketing, pharmaceutical manufacturing, and Chinese medicinal clinics. The company has retail chain stores and franchises, Multi-Level-Marketing branches, stockists and sales points, and GMP manufacturing plants across Malaysia. The product brands of the company include Health Food, Herbs, Medicated Tonic, medicine, wellness & Beauty, and others. The company has four reportable segments: Wholesale, Multi-level Marketing, Retail, and Investment holding. The company generates the majority of its revenue from the Investment holding segment.
57GF Score
Get the complete analysis for XKLS:7668
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7668 has been successfully added to your 
